Nakai, S., Honda, S., Matsumiya, W., Miki, A., & Nakamura, M. (2017). ARMS2 variants may predict the 3-year outcome of photodynamic therapy for wet age-related macular degeneration. Mol Vis.
Chicago Style CitationNakai, Shunichiro, Shigeru Honda, Wataru Matsumiya, Akiko Miki, i Makoto Nakamura. "ARMS2 Variants May Predict the 3-year Outcome of Photodynamic Therapy for Wet Age-related Macular Degeneration." Mol Vis 2017.
Cita MLANakai, Shunichiro, et al. "ARMS2 Variants May Predict the 3-year Outcome of Photodynamic Therapy for Wet Age-related Macular Degeneration." Mol Vis 2017.
Atenció: Aquestes cites poden no estar 100% correctes.